Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study.
Rebecka AhlPeter MatthiessenGabriel SjölinDhanisha Jayesh TrivediGöran WallinOlle LjungqvistShahin MohseniPublished in: BMJ open (2020)
Preoperative beta-blockade is associated with significant reductions in postoperative short-term and long-term mortality following elective colon cancer surgery. Its potential prophylactic effect warrants further interventional studies to determine whether beta-blockade can be used as a way of improving outcomes for this patient group.
Keyphrases
- patients undergoing
- minimally invasive
- coronary artery bypass
- surgical site infection
- case report
- risk factors
- stem cells
- cardiovascular disease
- mesenchymal stem cells
- type diabetes
- cross sectional
- coronary artery disease
- angiotensin converting enzyme
- insulin resistance
- metabolic syndrome
- weight loss
- glycemic control